Oncimmune Share News (ONC)

UK shareholder meetings calendar - next 7 days

CORRECT: Oncimmune works with Siemens Healthineers on cancer therapy

(Correcting headquarters location of Siemens Healthineers.)

Oncimmune enters collaboration with Siemens Healthineers

(Sharecast News) - Immunodiagnostics specialist Oncimmune announced a collaboration with Siemens Healthineers on Friday, to improve malignancy risk assessment of indeterminate pulmonary nodules (IPNs).

AIM WINNERS & LOSERS: Purplebricks drops as turnaround plan continues

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Oncimmune partners with Siemens Healthineers on lung cancer therapy

(Alliance News) - Oncimmune Holdings PLC on Friday said that it has collaborated with Siemens Healthineers AG, a Frankfurt-based medical technology company, in order to improve malignancy risk assessment in lung cancer.

TRADING UPDATES: FBD loses CFO; Eqtec wins GBP 2 million loan facility

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

UK earnings, trading statements calendar - next 7 days

Oncimmune shares plummet as company reports widened pretax loss

(Alliance News) - Oncimmune Holdings PLC on Wednesday reported a substantial widening in its pretax loss as administrative expenses increased in its end of year report.

AIM WINNERS & LOSERS: City Pub rises on profit swing; LBG Media falls

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

IN BRIEF: Oncimmune shares dip as Chair Meinhard Schmidt departs

Oncimmune Holdings PLC - Nottingham-based immunodiagnostics developer - Appoints Alistair MacDonald as new chair as now ex-chair Meinhard Schmidt retires from the board. Firm adds it has a pipeline of potential contracts. "I am delighted to be handing over the reins to Alistair with his wealth of experience in growing pharma services business," says Schmidt.

Oncimmune agrees two new commercial contracts

(Sharecast News) - Immunodiagnostics company Oncimmune announced the signing of two new commercial contracts for its 'ImmunoINSIGHTS' platform on Friday.

IN BRIEF: Oncimmune shares lifted on two new US contract wins

Oncimmune Holdings PLC - Nottingham-based immunodiagnostics developer - Signs two further ImmunoInsights commercial contracts. One contract is with an unnamed US-based clinical-stage biopharmaceutical company, that develops cellular immunotherapies for cancer patients. Oncimmune will provide the customer with its biomarker discover platform SeroTag to identify autoantibodies. Second contract is with another US clinical-stage biopharmaceutical company which is developing immune system-related technologies.

IN BRIEF: Oncimmune signs follow-on Covid autoimmunity contract

Oncimmune Holdings PLC - Nottingham-based immunodiagnostics developer - Signs follow-on contract with unnamed US research organisation to validate findings from prior study to assess the autoimmune response to Covid-19 infection.

TRADING UPDATES: IOG to cut Gazprom ties; wholesale changes at Donegal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News:

TRADING UPDATES: Profit rise for GlobalData, Greencoat keeps dividend

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: